356 related articles for article (PubMed ID: 11095910)
1. The role of endogenous growth factors to support corneal endothelial migration after wounding in vitro.
Schilling-Schön A; Pleyer U; Hartmann C; Rieck PW
Exp Eye Res; 2000 Dec; 71(6):583-9. PubMed ID: 11095910
[TBL] [Abstract][Full Text] [Related]
2. Intracellular signaling pathway of FGF-2-modulated corneal endothelial cell migration during wound healing in vitro.
Rieck PW; Cholidis S; Hartmann C
Exp Eye Res; 2001 Nov; 73(5):639-50. PubMed ID: 11747364
[TBL] [Abstract][Full Text] [Related]
3. Influence of vascular endothelial growth factor on bovine corneal endothelial cells in a wound-healing model.
Bednarz J; Thalmann-Goetsch A; Richard G; Engelmann K
Ger J Ophthalmol; 1996 May; 5(3):127-31. PubMed ID: 8803573
[TBL] [Abstract][Full Text] [Related]
4. New wound-healing model using cultured bovine corneal endothelial cells. 2. Role of migration and mitosis studied by immunohistochemistry.
Miyata K; Murao M; Sawa M; Tanishima T
Jpn J Ophthalmol; 1990; 34(3):267-74. PubMed ID: 2079771
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor stimulates corneal endothelial cell growth and endothelial wound healing of human corneas.
Hoppenreijs VP; Pels E; Vrensen GF; Treffers WF
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):931-44. PubMed ID: 8125756
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity.
Odekon LE; Sato Y; Rifkin DB
J Cell Physiol; 1992 Feb; 150(2):258-63. PubMed ID: 1734031
[TBL] [Abstract][Full Text] [Related]
7. Astrogliosis in culture. IV. Effects of basic fibroblast growth factor.
Hou YJ; Yu AC; Garcia JM; Aotaki-Keen A; Lee YL; Eng LF; Hjelmeland LJ; Menon VK
J Neurosci Res; 1995 Feb; 40(3):359-70. PubMed ID: 7745630
[TBL] [Abstract][Full Text] [Related]
8. Labeling of cycling corneal endothelial cells during healing with a monoclonal antibody to the Ki67 antigen (MIB-1).
Petroll WM; Jester JV; Bean J; Cavanagh HD
Cornea; 1999 Jan; 18(1):98-108. PubMed ID: 9894945
[TBL] [Abstract][Full Text] [Related]
9. FGF-2-induced wound healing in corneal endothelial cells requires Cdc42 activation and Rho inactivation through the phosphatidylinositol 3-kinase pathway.
Lee JG; Kay EP
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1376-86. PubMed ID: 16565371
[TBL] [Abstract][Full Text] [Related]
10. Corneal endothelial wound closure in vitro. Effects of EGF and/or indomethacin.
Joyce NC; Matkin ED; Neufeld AH
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1548-59. PubMed ID: 2787301
[TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacologic separation of corneal endothelial migration and spreading responses.
Joyce NC; Meklir B; Neufeld AH
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1816-26. PubMed ID: 2211027
[TBL] [Abstract][Full Text] [Related]
12. Involvement of P38MAPK in human corneal endothelial cell migration induced by TGF-β(2).
Joko T; Shiraishi A; Akune Y; Tokumaru S; Kobayashi T; Miyata K; Ohashi Y
Exp Eye Res; 2013 Mar; 108():23-32. PubMed ID: 23257207
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
14. Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis.
Grant MB; Khaw PT; Schultz GS; Adams JL; Shimizu RW
Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3292-301. PubMed ID: 1428704
[TBL] [Abstract][Full Text] [Related]
15. Corneal endothelial modulation: bFGF as direct mediator and corneal endothelium modulation factor as inducer.
Kay EP; Gu X; Smith RE
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2427-35. PubMed ID: 8163333
[TBL] [Abstract][Full Text] [Related]
16. Effects of basic FGF and TGF beta 1 on F-actin and ZO-1 organization during cat endothelial wound healing.
Petroll WM; Jester JV; Barry-Lane PA; Cavanagh HD
Cornea; 1996 Sep; 15(5):525-32. PubMed ID: 8862930
[TBL] [Abstract][Full Text] [Related]
17. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro.
Rieck P; Oliver L; Engelmann K; Fuhrmann G; Hartmann C; Courtois Y
Exp Cell Res; 1995 Sep; 220(1):36-46. PubMed ID: 7664841
[TBL] [Abstract][Full Text] [Related]
18. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
19. ERK1/2 activation regulates the wound healing process of rabbit corneal endothelial cells.
Chen WL; Lin CT; Li JW; Hu FR; Chen CC
Curr Eye Res; 2009 Feb; 34(2):103-11. PubMed ID: 19219681
[TBL] [Abstract][Full Text] [Related]
20. New wound-healing model using cultured corneal endothelial cells. 1. Quantitative study of healing process.
Miyata K; Murao M; Sawa M; Tanishima T
Jpn J Ophthalmol; 1990; 34(3):257-66. PubMed ID: 2079770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
